Plasma sphingolipids and depressive symptoms in coronary artery disease.
Adam DinoffMahwesh SaleemNathan HerrmannMichelle M MielkePaul I OhSwarajya Lakshmi Vattem VenkataNorman J HaugheyKrista L LanctôtPublished in: Brain and behavior (2017)
Sphingolipids, in particular the ceramide species C16:0 and C18:0 and the sphingomyelin species SM18:1, may be implicated in the pathophysiology of depression in CAD. The association between plasma sphingolipid concentrations and depression should be further examined in CAD patients and in other populations.
Keyphrases
- coronary artery disease
- depressive symptoms
- end stage renal disease
- sleep quality
- ejection fraction
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- social support
- cardiovascular events
- peritoneal dialysis
- genetic diversity
- coronary artery bypass grafting
- cardiovascular disease
- patient reported outcomes
- aortic stenosis
- atrial fibrillation
- transcatheter aortic valve replacement